Page 16 - Shimadzu Journal vol.3 Issue3
P. 16

Drug Discovery





              Utility of high resolution MALDI imaging in drug discovery:
              Histological distribution of gentamicin in proximal renal tubules of rats

            *Part of this work was presented in a poster session of the 63th ASMS Conference, May 13 - June 4, 2015, St. Luis.
                                                                2
                                                  1
                                     1
                      1
            Hidefumi Kaji ; Hiroyuki Hashimoto ; Masayoshi Saito ; Takushi Yamamoto ; Noriyuki Ojima 2
            1: Mitsubishi Tanabe Pharma Corporation, Saitama, Japan
            2: Shimadzu Corporation, Kyoto, Japan
            Overview
                                                                          Observation        MALDI imaging
            ⾣ MS/MS imaging of gentamicin was performed from high-selectivity
              analysis of endogenous metabolites in biological tissue.
            ⾣ High resolution (10 µm) imaging of rat renal cortex showed that       Movement
              gentamicin is specifically distributed in proximal renal tubules.
            ⾣ New matrix application method is useful for the sensitive MALDI
              imaging.
                                                                               Imaging Mass Microscope
            1. Introduction
                                                                               Laser: Nd:YAG laser (335 nm)
            In pharmacology and toxicology, localization of a drug molecule in the   Collision energy: 50
                                                                               Laser shot: 200 shot/pixcel
            target tissue of organs provides very important in vivo biological   Laser diameter: 50 or 10 µm
            information. Imaging mass spectrometry (IMS) is increasingly used in   Matrix: CHCA
            drug discovery and development during preclinical studies.
            Gentamicin is an antibiotic to treat infections, but it possesses renal   Structures of Gentamicin
            toxicity. As it is excreted in the urine, the kidney tissues of a person   We analyzed gentamicin C1, because it had the highest efficacy.
            being treated with gentamicin are almost constantly bathed in
            gentamicin. The objective of the study is to define the specific
            distribution of the parent drug in proximal renal tubules of rats dosed
            gentamicin using MALDI imaging.

            2. Methods
            At 2 h after single intravenous (I.V.) administration (3, 10, or 30
                                                               Sample preparation
            mg/kg) of gentamicin to male SD rats, 5-µm sections taken from the
            single kidney of each rat were prepared. The tissue sections were
            coated with CHCA by sublimation using an automated sample
            treatment system (iMLayer™, Shimadzu Corporation, Japan), and
            analyzed using an ion trap-time of flight (IT-TOF) tandem mass
            spectrometer equipped with MALDI source†. This instrument is a
                                                                  I.V. administration  Extraction of kidneys  Snap-freeze in
            combination of an optical microscope which allows the observation of                     liquid nitrogen
            high-resolution morphological images, with a mass spectrometer
            which identifies and visualizes the distribution of specific molecules.
                                                                            Pretreatment
            The other kidney was used for determining the concentrations of   LC-MS/MS
            gentamicin by LC-MS/MS.
                                                                                  Homoginized kidney



                                                                 IMS



                                                                                                   Cryosectioned (10 µm)

                                                                    Matrix application
                                 iMLayer™
                                                                    Spray: 10 mg/mL CHCA, 0.1% TFA in 60% acetonitrile solution
                        (Matrix Vapor Deposition System, Shimadzu)
                                                                    Sublimation: time; 20 min, thickness; ca.2 µm
                       High reproducibility and minute matrix crystals
                                                                    Nebulizer: applied methanol mist, 5 min, particle size:  <5 µm
                                                                    Pre-coated matrix: sublimation before thaw-mounted tissue section

      72
   11   12   13   14   15   16   17   18   19   20   21